{
    "root": "b4fff30d-25fe-4b44-aff2-cd02cc251a1c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "VOWST",
    "value": "20250321",
    "ingredients": [
        {
            "name": "DONOR HUMAN STOOL SPORES (ETHANOL TREATED)",
            "code": "9K7X6R5BMW"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        }
    ],
    "indications": "VOWST is indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI).",
    "contraindications": "For oral administration only. ( 2 ) Prior to taking the first dose: Complete antibacterial treatment for rCDI 2 to 4 days before initiating treatment with VOWST. ( 2.1 ) Drink 296 mL (10 oz) of magnesium citrate on the day before and at least 8 hours prior to taking the first dose of VOWST. In clinical studies, participants with impaired kidney function received polyethylene glycol electrolyte solution (250 mL GoLYTELY, not approved for this use). ( 2.1 ) The dosage of VOWST is 4 capsules taken orally once daily for 3 consecutive days. ( 2.2 ) Take each dose (4 capsules) on an empty stomach prior to the first meal of the day. ( 2.2 )",
    "warningsAndPrecautions": "VOWST is supplied as capsules in bottles with child-resistant caps. Each bottle contains 12 white capsules imprinted with \"SER109\". Each bottle is supplied in a carton.\n                  Bottles of 12 capsules:  NDC 71881-400-12.",
    "adverseReactions": "None."
}